Home › Idiopathic Thrombocytopenic Purpura › California
Idiopathic Thrombocytopenic Purpura clinical trials in California
10 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in California.
Cities in California
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University, Palo Alto
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- MemorialCare Long Beach Medical Center, Long Beach
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 17, 2026 · NCT07700238Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Usc Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- University of Southern California, Los Angeles
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- City of Hope, Duarte
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT07083960Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of California-Irvine, Orange
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates), Clovis
- University of Southern California (USC), Los Angeles
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
- Sharp Memorial Hospital, Oceanside
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.